IL15 and neoplasm: A human NKG2D–IL-15 fusion protein could efficiently bind to major histocompatibility complex class I polypeptide-related sequence+ tumor cells and stimulated NK cell activity by transpresentation of IL-15, thus exhibiting higher control efficiency of the growth of xenografted human gastric cancer via the NK cell recruitment and activation (55).